South and Central America Invasive Neurostimulation Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033
The South and Central America invasive neurostimulation devices market size is expected to reach US$ 401.6 million by 2033 from US$ 266.5 million in 2025. The market is estimated to register a CAGR of 5.3% from 2026 to 2033.
Report Coverage
- Product Type: Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Other Product Types
- Application: Pain & Sensory Modulation, Functional Disorders, Cognitive & Behavioral Regulation, and Other Applications
- End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Other End Users
US$ 266.5 Mn
Market size in 2025
US$ 401.6 Mn
Market Size by 2033
5.3%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Invasive Neurostimulation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Invasive Neurostimulation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Invasive Neurostimulation Devices Market Regional Analysis
6.2 South and Central America Invasive Neurostimulation Devices Market Revenue 2022-2033 (US$ Million)
6.3 South and Central America Invasive Neurostimulation Devices Market Forecast Analysis
7. South and Central America Invasive Neurostimulation Devices Market Analysis – by Product Type
7.1 Spinal Cord Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Spinal Cord Stimulation Devices: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 Deep Brain Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Deep Brain Stimulation Devices: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Sacral Nerve Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Sacral Nerve Stimulation Devices: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Vagus Nerve Stimulation Devices
- 7.4.1 Overview
- 7.4.2 Vagus Nerve Stimulation Devices: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.5 Other Product Types
- 7.5.1 Overview
- 7.5.2 Other Product Types: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8. South and Central America Invasive Neurostimulation Devices Market Analysis – by Application
8.1 Pain & Sensory Modulation
- 8.1.1 Overview
- 8.1.2 Pain & Sensory Modulation: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Functional Disorders
- 8.2.1 Overview
- 8.2.2 Functional Disorders: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.3 Cognitive & Behavioral Regulation
- 8.3.1 Overview
- 8.3.2 Cognitive & Behavioral Regulation: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9. South and Central America Invasive Neurostimulation Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
10. South and Central America Invasive Neurostimulation Devices Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America- 10.2.1 South and Central America Invasive Neurostimulation Devices Market Breakdown, by Key Country, 2026 and 2033 (%)
- 10.2.1.1 South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Brazil: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.1.1 Brazil: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 Brazil: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South and Central America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.2 Argentina: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.2.1 Argentina: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Argentina: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South and Central America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.3 Chile: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.3.1 Chile: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 Chile: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.3.3 Chile: South and Central America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.4 Colombia: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.4.1 Colombia: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.4.2 Colombia: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.4.3 Colombia: South and Central America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.5 Peru: South and Central America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.5.1 Peru: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.5.2 Peru: South and Central America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.5.3 Peru: South and Central America Invasive Neurostimulation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Medtronic
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abbott
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 LivaNova PLC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nevro Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NeuroPace, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Newronika S.p.A.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Saluda Medical Pty Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Biotronik
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Mainstay Medical
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full S Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.